KESTRA MEDICAL TECHNOLOGIES ($KMTS) posted quarterly earnings results for Q2 2026 on Thursday, December 11th. The company reported earnings of -$0.62 per share, missing estimates of -$0.60 by $0.02. The company also reported revenue of $22,570,000, beating estimates of $21,117,906 by $1,452,094.
You can see Quiver Quantitative's $KMTS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KESTRA MEDICAL TECHNOLOGIES Hedge Fund Activity
We have seen 55 institutional investors add shares of KESTRA MEDICAL TECHNOLOGIES stock to their portfolio, and 42 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,582,693 shares (+42.8%) to their portfolio in Q3 2025, for an estimated $37,604,785
- CITADEL ADVISORS LLC removed 1,508,298 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $35,837,160
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,299,391 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $30,873,530
- PRICE T ROWE ASSOCIATES INC /MD/ added 842,382 shares (+84.5%) to their portfolio in Q3 2025, for an estimated $20,014,996
- BROWN ADVISORY INC added 679,335 shares (+117.1%) to their portfolio in Q3 2025, for an estimated $16,140,999
- HOOD RIVER CAPITAL MANAGEMENT LLC added 395,238 shares (+inf%) to their portfolio in Q3 2025, for an estimated $9,390,854
- ORBIMED ADVISORS LLC removed 250,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,144,999
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KESTRA MEDICAL TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $KMTS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 11/18/2025
- Wells Fargo issued a "Overweight" rating on 07/17/2025
To track analyst ratings and price targets for KESTRA MEDICAL TECHNOLOGIES, check out Quiver Quantitative's $KMTS forecast page.
KESTRA MEDICAL TECHNOLOGIES Price Targets
Multiple analysts have issued price targets for $KMTS recently. We have seen 2 analysts offer price targets for $KMTS in the last 6 months, with a median target of $29.5.
Here are some recent targets:
- Marie Thibault from BTIG set a target price of $32.0 on 11/18/2025
- Larry Biegelsen from Wells Fargo set a target price of $27.0 on 07/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
